Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies
- PMID: 18381509
- DOI: 10.1542/peds.2007-1659
Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies
Abstract
Objective: The purpose of this work was to analyze outcome with focus on growth in infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies and identify maternal factors other than the autoantibodies increasing the risk of fetal heart block.
Patients and methods: Thirty-two pregnancies in 30 anti-Ro52-positive mothers were included. Seven fetuses developed second-degree or third-degree atrioventricular block, 8 developed first-degree atrioventricular block, and 17 had normal atrioventricular conduction, as diagnosed by using Doppler echocardiography. Three of 6 surviving fetuses with second-degree or third-degree atrioventricular block received treatment with fluorinated steroids. Two fetuses with second-degree atrioventricular block converted to first-degree atrioventricular block without any signs of progression during the study period. Maternal and longitudinal infant data were collected from planned neonatal follow-up and childhood health records from birth to 12 months of age in 31 survivors.
Results: Women giving birth to infants with prenatal second-degree or third-degree atrioventricular block were older and with higher parity than those with first-degree atrioventricular block or normal atrioventricular conduction. Second-degree or third-degree atrioventricular block pregnancies were <40 completed weeks, whereas pregnancies with first-degree atrioventricular block or normal atrioventricular conduction had a normal duration. Fetuses with second-degree or third-degree atrioventricular block were retarded by -0.98 +/- 0.77 SD in weight at birth and did not show any catch-up during infancy. In contrast, fetuses with first-degree atrioventricular block or normal atrioventricular conduction had a weight reduction of -0.51 +/- 1.01 SD with a catch-up during the first months after birth.
Conclusions: This report documents that newborns with autoantibody-mediated second-degree or third-degree atrioventricular block are retarded in growth, with no catch-up during infancy, whereas fetuses with first-degree atrioventricular block or normal atrioventricular conduction have a normal growth soon after birth. Increased maternal age and/or parity seem to carry an increased risk for fetal heart block.
Similar articles
-
Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Curr Opin Rheumatol. 2009. PMID: 19584727 Review.
-
Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.Arthritis Rheum. 1999 Nov;42(11):2335-45. doi: 10.1002/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3. Arthritis Rheum. 1999. PMID: 10555029
-
The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.J Am Coll Cardiol. 2010 Jun 15;55(24):2778-84. doi: 10.1016/j.jacc.2010.02.042. J Am Coll Cardiol. 2010. PMID: 20538173
-
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.Rheumatology (Oxford). 2007 Aug;46(8):1285-9. doi: 10.1093/rheumatology/kem073. Epub 2007 Apr 20. Rheumatology (Oxford). 2007. PMID: 17449486
-
Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.Circulation. 2004 Sep 21;110(12):1542-8. doi: 10.1161/01.CIR.0000142046.58632.3A. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353508 Review.
Cited by
-
Atrioventricular block during fetal life.J Saudi Heart Assoc. 2015 Jul;27(3):164-78. doi: 10.1016/j.jsha.2014.07.001. Epub 2014 Jul 10. J Saudi Heart Assoc. 2015. PMID: 26136631 Free PMC article. Review.
-
Overview of fetal arrhythmias.Curr Opin Pediatr. 2008 Oct;20(5):522-31. doi: 10.1097/MOP.0b013e32830f93ec. Curr Opin Pediatr. 2008. PMID: 18781114 Free PMC article. Review.
-
Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study.Am J Cardiol. 2009 Apr 15;103(8):1102-6. doi: 10.1016/j.amjcard.2008.12.027. Epub 2009 Mar 4. Am J Cardiol. 2009. PMID: 19361597 Free PMC article. Clinical Trial.
-
Effects of maternal anti-Ro/La antibodies on fetal atrioventricular conduction evaluated with echocardiography: a state-of-the-art review.Arch Gynecol Obstet. 2025 Jun 11. doi: 10.1007/s00404-025-08092-6. Online ahead of print. Arch Gynecol Obstet. 2025. PMID: 40500420 Review.
-
Prenatal diagnosis of fetal bradyarrhythmia and postnatal outcome.Indian Pacing Electrophysiol J. 2024 Jan-Feb;24(1):20-24. doi: 10.1016/j.ipej.2023.10.003. Epub 2023 Oct 13. Indian Pacing Electrophysiol J. 2024. PMID: 37838306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials